Lv41
524 积分 2024-03-27 加入
Belimumab ameliorates symptoms and disease activity in patients with dermatomyositis and juvenile dermatomyositis refractory to standard therapy: A retrospective observational study
4小时前
待确认
How to score version 2 of the SF-12(R) health survey (with a supplement documenting version 1)
4天前
已关闭
Erratum to The MOS 36-item short form health survey (SF-36): I. Conceptual framework
4天前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
7天前
已关闭
Idiopathic inflammatory myopathies
12天前
已完结
Idiopathic inflammatory myopathies: current insights and future frontiers
13天前
已完结
Update on outcome assessment in myositis
18天前
已完结
Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke
1个月前
已完结
Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial
1个月前
已完结
皖公网安备34019202002308
